Sensimed Holds First Close for Series C

Sensimed AG said that it has held a first close of its Series C round, netting $17.9 million. Wellington Partners, Agate Medical Investments and Vinci Capital/Renaissance PME co-led the round. Other investors include Sandoz Family Foundation and ELM Development. Sensimed AG, a Swiss company, develops a “non-invasive soft contact lens-based solution” to help treat glaucoma.

North AmericaUSBriefs